Authors:
ZAWERTAILO LA
KAPLAN HL
BUSTO UE
TYNDALE RF
SELLERS EM
Citation: La. Zawertailo et al., PSYCHOTROPIC EFFECTS OF DEXTROMETHORPHAN ARE ALTERED BY THE CYP2D6 POLYMORPHISM - A PILOT-STUDY, Journal of clinical psychopharmacology, 18(4), 1998, pp. 332-337
Authors:
ROMACH MK
KAPLAN HL
BUSTO UE
SOMER G
SELLERS EM
Citation: Mk. Romach et al., A CONTROLLED TRIAL OF ONDANSETRON, A 5-HT3 ANTAGONIST, IN BENZODIAZEPINE DISCONTINUATION, Journal of clinical psychopharmacology, 18(2), 1998, pp. 121-131
Authors:
BUSTO UE
SELLERS EM
KAPLAN HL
WRIGHT CE
GREENBLATT DJ
Citation: Ue. Busto et al., PHARMACOKINETIC PHARMACODYNAMIC EVALUATION OF ALPRAZOLAM SUSTAINED-RELEASE, BROMAZEPAM (B) AND LORAZEPAM (L)/, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 113-113
Authors:
KAPLAN HL
BUSTO UE
BAYLON GJ
CHEUNG SW
OTTON SV
SOMER G
SELLERS EM
Citation: Hl. Kaplan et al., INHIBITION OF CYTOCHROME-P450 2D6 METABOLISM OF HYDROCODONE TO HYDROMORPHONE DOES NOT IMPORTANTLY AFFECT ABUSE LIABILITY, The Journal of pharmacology and experimental therapeutics, 281(1), 1997, pp. 103-108
Authors:
ROMACH MK
KATHIRAMALAINATHAN K
KAPLAN HL
BUSTO UE
TYNDALE RF
SELLERS EM
Citation: Mk. Romach et al., CODEINE ABUSE LIABILITY IS MODIFIED BY CYP2D6 INHIBITION, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 107-107
Citation: Em. Sellers et al., TOBACCO AND OTHER DRUG-DEPENDENCE INCREASES VARIATION IN CYTOCHROME-P450 3A ACTIVITY (CYP3A) IN FEMALES, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 108-108
Authors:
OCAMPO JA
BUSTO UE
KAPLAN HL
TYNDALE RF
OTTON SV
NOLTE H
SYMANZIK C
SELLERS EM
Citation: Ja. Ocampo et al., DOES EXTENT OF P-HYDROXYLATION ALTER METHAMPHETAMINE KINETICS, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 83-83
Authors:
ZAWERTAILO LA
BUSTO U
KAPLAN HL
SELLERS EM
Citation: La. Zawertailo et al., COMPARATIVE ABUSE LIABILITY OF SERTRALINE, ALPRAZOLAM, AND DEXTROAMPHETAMINE IN HUMANS, Journal of clinical psychopharmacology, 15(2), 1995, pp. 117-124
Authors:
ROMACH M
BUSTO U
SOMER G
KAPLAN HL
SELLERS E
Citation: M. Romach et al., CLINICAL ASPECTS OF CHRONIC USE OF ALPRAZOLAM AND LORAZEPAM, The American journal of psychiatry, 152(8), 1995, pp. 1161-1167
Authors:
BUSTO U
KAPLAN HL
ZAWERTAILO L
SELLERS EM
Citation: U. Busto et al., PHARMACOLOGICAL EFFECTS AND ABUSE LIABILITY OF BRETAZENIL, DIAZEPAM, AND ALPRAZOLAM IN HUMANS, Clinical pharmacology and therapeutics, 55(4), 1994, pp. 451-463
Authors:
ZAWERTAILO L
BUSTO U
KAPLAN HL
SELLERS EM
Citation: L. Zawertailo et al., COMPARATIVE ABUSE LIABILITY OF MEPROBAMATE, BUTABARBITAL AND TRIAZOLAM IN RECREATIONAL DRUG-USERS, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 133-133
Authors:
KAPLAN HL
SWITZER WG
HINDERER RK
ANZUETO A
Citation: Hl. Kaplan et al., A STUDY ON THE ACUTE AND LONG-TERM EFFECTS OF HYDROGEN-CHLORIDE ON RESPIRATORY RESPONSE AND PULMONARY-FUNCTION AND MORPHOLOGY IN THE BABOON, Journal of fire sciences, 11(6), 1993, pp. 459-484
Authors:
KAPLAN HL
SWITZER WG
HINDERER RK
ANZUETO A
Citation: Hl. Kaplan et al., ACUTE AND LONG-TERM EFFECTS OF POLYVINYLCHLORIDE (PVC) SMOKE ON THE RESPIRATORY SYSTEM OF THE BABOON AND A COMPARISON WITH THE EFFECTS HYDROGEN-CHLORIDE (HCL), Journal of fire sciences, 11(6), 1993, pp. 485-511
Authors:
KAPLAN HL
SWITZER WG
HINDERER RK
ANZUETO A
Citation: Hl. Kaplan et al., STUDIES OF THE EFFECTS OF HYDROGEN-CHLORIDE AND POLYVINYLCHLORIDE (PVC) SMOKE IN RODENTS, Journal of fire sciences, 11(6), 1993, pp. 512-552
Authors:
OTTON SV
SCHADEL M
CHEUNG SW
KAPLAN HL
BUSTO UE
SELLERS EM
Citation: Sv. Otton et al., CYP2D6 PHENOTYPE DETERMINES THE METABOLIC CONVERSION OF HYDROCODONE TO HYDROMORPHONE, Clinical pharmacology and therapeutics, 54(5), 1993, pp. 463-472